Newly-completed rbbFGF production expansion that’s 4x bigger
Higher-value-added product offerings and expanding treatment areas: 2nd-generation eye gels and single-use eye drops for corneal injury, plus wound-healing drugs, glaucoma eye drops, etc.
Bigger and more differentiated sales force to boost market shares in existing accounts and new county-level hospital coverage